Type 1 Diabetes Extension Study
Tocilizumab (TCZ) in New-onset Type 1 Diabetes
Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1
Pathway to Prevention Study
† Indicates status has not been verified in more than two years